semaglutide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42557064
Efficacy and Hypoglycaemia Outcomes With Once-Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1-3 Trials.
Efficacy and Hypoglycaemia Outcomes With Once-Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1-3 Trials.
- 저자
- Linong Ji, Jonas Dahl Andersen, Malik Benamar, Paola Ponzani, A G Unnikrishnan, Siri Vinther
- 저널
- Diabetes, obesity & metabolism
- 공개일
- 2026 Aug 05
- 연구 유형
- 기타
- DOI
- 10.1111/dom.70895
문헌 요약
This post hoc analysis of COMBINE 1-3 assessed efficacy and hypoglycaemia outcomes with IcoSema (once-weekly combination therapy of basal insulin icodec and semaglutide [a glucagon-like peptide-1 analogue]) versus comparators in adults with type 2 diabetes (T2D) by kidney and liver function subgroups. Treatment outcomes were analysed by trial according to…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.